Deferred Income Tax Liabilities, Net in USD of OptimizeRx Corp from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
OptimizeRx Corp quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2023 to Q3 2025.
  • OptimizeRx Corp Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $4.49M, a 65.6% increase year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

OptimizeRx Corp Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $4.49M +$1.78M +65.6% 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $3.46M -$879K -20.3% 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $3.79M -$551K -12.7% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $4.49M +$154K +3.55% 31 Dec 2024 10-Q 07 Nov 2025
Q3 2024 $2.71M 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $4.34M 30 Jun 2024 10-Q 15 Aug 2024
Q1 2024 $4.34M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $4.34M 31 Dec 2023 10-K 20 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.